ArticleArchives of osteoporosis2025

Comparable fracture risk between orexin and melatonin receptor agonists: integrating active-comparator and population-based evidence.

Kei Muroi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.